Comparing the current results to its competitors, Clover Health Investments reported Revenue increase in the 2 quarter 2026 by 55.6 % year on year. The sales growth was above Clover Health Investments 's competitors' average revenue growth of 13.67 %, achieved in the same quarter.
Clover Health Investments Corp achieved net profit of $28.00 millions compared to a net loss of $-10.58 millions recorded in the same quarter a year ago.
Clover Health Investments 's Comment on Competition and Industry Peers
The company operates in the physician enablement and Medicare segments, including Medicare Advantage (MA) and Original Medicare. Its competitors include incumbent MA sponsors that develop their own technology or collaborate with third-party providers. Major national insurers offering MA plans include United Health, Aetna, Humana, Centene, and Elevance Health. Regional companies and health plans providing MA plans include Blue Cross Blue Shield affiliates, Alignment Health, Devoted Health, and Oscar Health, as well as hospital systems and provider-based organizations. The market is characterized by rapidly evolving technologies, changing regulations, new product offerings, and shifting preferences among beneficiaries and providers.
Due to outstanding performance in Overall company, revenue grew by 55.6 % Clover Health Investments Corp improved its market share, to approximately 1.25 %.
March 3, 2025
In an era where the intersection of technology and healthcare is becoming increasingly critical, the recent partnership between Counterpart Health and Google Cloud marks a significant evolution in how physicians can access and utilize clinical data. This collaboration introduces enhanced functionality within the Counterpart Assistant, employing Google Cloud’s Vertex AI Search to provide clinicians with comprehensive insights drawn from multiple patient health data sources. The primary of this integration is to streamline the workflow of healthcare providers by simplifying access to the vast amounts of patient information that can exist across disparate systems. As the healthcare sector increasingly turns ...
September 3, 2024
In a move that underscores the ongoing transformation of the healthcare landscape through technology, Counterpart Health, Inc. has announced a significant multi-year agreement with The Iowa Clinic, one of the most respected multispecialty healthcare groups in the United States. This partnership, revealed on September 3, 2024, signals Counterpart s intent to deploy its AI-powered physician enablement platform to hundreds of providers across the Midwest, thus positioning the company to exert a considerable influence on regional healthcare delivery models. Transformational Technology in Healthcare The deployment of Counterpart s proven AI technology aims to better empower physicians in their roles, enhancing pa...
May 29, 2024
Clover Health Unveils Counterpart Health: Revolutionizing Medicare Advantage with Data-Driven Technology FRANKLIN, Tenn., May 29, 2024 - In a transformative leap for the healthcare industry, Clover Health Investments, Corp. (NASDAQ: CLOV) today announced the launch of Counterpart Health, a pioneering SaaS and tech-enabled services solution designed to extend the capabilities of Clover’s flagship clinical decision support tool to all Medicare Advantage payors and providers. This innovative offering, now branded as Counterpart Assistant (CA), signifies a strategic expansion aimed at democratizing access to advanced healthcare analytics and personalized care across the Medicare landscape.Clover Health, reco...
January 8, 2024
Primary Care Providers (PCPs) that incorporate the use of Clover Assistant into their routine practice are witnessing a significant increase in medication fills for patients who were previously non-compliant, according to a recent press release. Greater fill rates have led to an improvement in performance on medication adherence quality measures within the Medicare Advantage Stars program for members where Clover Assistant was utilized.Clover Assistant, a leading-edge technology platform developed by Clover Health, empowers doctors at the point of care by aggregating patient data from diverse sources into one unified system. This robust tool enhances patient and provider engagement while aiming to optimize c...
Franklin, Tenn. - In a strategic move to accelerate its path to profitability, Clover Health Investments, Corp. (NASDAQ: CLOV), a leading physician enablement company focused on providing access to high-quality healthcare for Medicare beneficiaries, has announced its decision to exit the Centers for Medicare and Medicaid Services (CMS) ACO REACH Program at the end of the 2023 performance year. This calculated step aims to optimize operational efficiency while maintaining the commitment to providing exceptional care to their ACO REACH beneficiaries. Background: The CMS ACO REACH Program, designed to promote coordinated care and improve healthcare outcomes, has witnessed Clover Health diligen...
Oscar Health Inc is a health insurance company that utilizes technology and data-driven approaches to provide digital and personalized healthcare experiences for its customers. Their business model focuses on simplifying the health insurance process and improving access to care through a user-friendly platform and innovative strategies.
Humana Inc.s business model focuses on providing a wide range of health insurance products and healthcare services to individuals and groups. The company generates revenue primarily through the sale of Medicare, Medicaid, and commercial insurance plans, as well as by operating healthcare facilities and clinics. Their mission is to enhance customer health outcomes by delivering accessible, affordable, and integrated healthcare solutions tailored to the needs of their members.
Emmaus Life Sciences Inc's business model revolves around the development and commercialization of innovative pharmaceutical products, with a focus on the treatment and management of rare diseases and conditions. They aim to bring these life-saving therapies to market by conducting research, obtaining regulatory approvals, and establishing partnerships with healthcare providers and stakeholders.
Sources:
Clover Health Investments Corp’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Clover Health Investments Corp versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
